Home Cart 0 Sign in  
X

[ CAS No. 17012-21-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 17012-21-4
Chemical Structure| 17012-21-4
Chemical Structure| 17012-21-4
Structure of 17012-21-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 17012-21-4 ]

Related Doc. of [ 17012-21-4 ]

Alternatived Products of [ 17012-21-4 ]

Product Details of [ 17012-21-4 ]

CAS No. :17012-21-4 MDL No. :MFCD04038678
Formula : C13H17NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :GDWFCUOFVSNTTG-UHFFFAOYSA-N
M.W : 219.28 Pubchem ID :4610751
Synonyms :

Calculated chemistry of [ 17012-21-4 ]

Physicochemical Properties

Num. heavy atoms : 16
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.46
Num. rotatable bonds : 4
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 66.23
TPSA : 29.54 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.4 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.7
Log Po/w (XLOGP3) : 1.75
Log Po/w (WLOGP) : 1.15
Log Po/w (MLOGP) : 1.86
Log Po/w (SILICOS-IT) : 2.11
Consensus Log Po/w : 1.91

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.32
Solubility : 1.06 mg/ml ; 0.00484 mol/l
Class : Soluble
Log S (Ali) : -1.99
Solubility : 2.26 mg/ml ; 0.0103 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.1
Solubility : 0.174 mg/ml ; 0.000794 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.02

Safety of [ 17012-21-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 17012-21-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 17012-21-4 ]
  • Downstream synthetic route of [ 17012-21-4 ]

[ 17012-21-4 ] Synthesis Path-Upstream   1~15

  • 1
  • [ 17012-21-4 ]
  • [ 5731-17-9 ]
YieldReaction ConditionsOperation in experiment
88% With sodium sulfate In tetrahydrofuran A.
1-Benzylpyrrolidine-3-methanol
To a mixture of methyl 1-benzylpyrrolidine-3-carboxylate (11.67 g, 50 mmol) and tetrahydrofuran, at 0° C. was added lithium aluminum hydride (3.795 g, 100 mmol).
The reaction was warmed to room temperature and refluxed for 24 hours.
After cooling to 0° C., the reaction was quenched with saturated sodium sulfate and warmed to room temperature.
Tetrahyrofuran (50 mL) and solid sodium sulfate were added to the mixture.
After stirring for 1 hour, the mixture was filtered and the filtrate was concentrated and vacuum dried for 3 days to give the title compound as a colorless oil (8.49 g, 88percent).
1H-NMR (300 MHz, DMSO-d6): 7.21-7.31 (m, 5H), 4.50 (t, J=5.3 Hz, 1H), 3.51 (s, 2H), 3.20-3.31 (m, 2H), 2.35-2.50 (m, 4H), 2.10-2.27 (m, 1H), 1.70-1.85 (m, 1H), 1.27-1.43 (m, 1H). IS-MS, m/e: 192.4 (m+1).
Reference: [1] Patent: US6635657, 2003, B1,
  • 2
  • [ 51535-00-3 ]
  • [ 17012-21-4 ]
Reference: [1] Chemistry - A European Journal, 2017, vol. 23, # 9, p. 2005 - 2009
[2] Tetrahedron Letters, 1999, vol. 40, # 19, p. 3673 - 3676
[3] European Journal of Organic Chemistry, 2005, # 4, p. 673 - 682
[4] Journal of Medicinal Chemistry, 1999, vol. 42, # 25, p. 5254 - 5265
[5] Organic Letters, 1999, vol. 1, # 5, p. 799 - 801
[6] Patent: US2003/229226, 2003, A1, . Location in patent: Page 14
[7] Patent: WO2004/14910, 2004, A1, . Location in patent: Page 69-70
[8] Patent: EP307140, 1989, A1,
  • 3
  • [ 93102-05-7 ]
  • [ 292638-85-8 ]
  • [ 17012-21-4 ]
YieldReaction ConditionsOperation in experiment
1420 g With trifluoroacetic acid In dichloromethane at 0 - 20℃; Large scale To a 250 mL multi-vial was added 1530.0 g (6.5 mol) of benzylmethoxymethyltrimethylsilylmethylamine,31.80 g (3.7 mol)Methyl acrylate and 38 mL of dichloromethane,A solution of 44.0 g (0.4 mol) of trifluoroacetic acid at a mass concentration of 10percent was slowly added dropwise at 0 ° C,After completion of the dropwise addition, the mixture was stirred at room temperature overnight, and the mixture was concentrated under reduced pressure,The residueRespectively, washed with saturated sodium bicarbonate solution and saturated sodium chloride solution,Combined organic phase,The organic phase passes through anhydrous sulfuric acidSodium drying, filtration,The filtrate was concentrated under reduced pressure,To obtain 1420.0 g of crude 1-benzylpyrrolidine-3-carboxylate as a crude product 100percent.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 19, p. 4861 - 4866
[2] Organic Process Research and Development, 2009, vol. 13, # 2, p. 292 - 296
[3] Synthesis, 2006, # 16, p. 2646 - 2648
[4] Synlett, 2015, vol. 26, # 13, p. 1815 - 1818
[5] Chemical & Pharmaceutical Bulletin, 1985, vol. 33, # 7, p. 2762 - 2766
[6] Tetrahedron Letters, 2011, vol. 52, # 26, p. 3266 - 3270
[7] Patent: CN104817549, 2017, B, . Location in patent: Paragraph 0036-0038
  • 4
  • [ 93102-06-8 ]
  • [ 292638-85-8 ]
  • [ 17012-21-4 ]
Reference: [1] Chemistry Letters, 1984, p. 1117 - 1120
  • 5
  • [ 50-00-0 ]
  • [ 53215-95-5 ]
  • [ 292638-85-8 ]
  • [ 17012-21-4 ]
YieldReaction ConditionsOperation in experiment
10.4 g
Stage #1: With N,N,N',N'-tetramethylguanidine In tetrahydrofuran at 20℃; for 1.5 h;
Stage #2: With trifluoroacetic acid In tetrahydrofuran
Paraformaldehyde (1.72 g, 54.3 mmol) was charged in the reactor followed by 100 mL THF and Benzyl-trimethylsilanylmethyl-amine (5) (10 g, 51.7 mmol). 1,1,3,3-tetramethylguanidine (119 mg, 130 μ, 1.03 mmol) was added to the suspension. The reaction mixture was stirred at RT for 1.5 h during which a clear solution was obtained. This solution was added dropwise over 30 min to a mixture consisting of TFA (301 mg, 203 μ, 2.59 mmol) and methyl acrylate (4.95 g, 56.9 mmol). After completion of the reaction (IPC by GC or HPLC, ca 3-5 h), the reaction mixture was concentrated under reduced pressure. The oily residue was dissolved in 25 mL MTBE and was washed twice washed with 60 mL water (60.0 g, 60 mL), then with 30 mL half saturated NaHC03 aq and 25 mL half saturated NaClaq. The organic phase was dried over MgS04, filtered and concentrated under reduced pressure to give 10.4 g of product (21) (89percent yield).
Reference: [1] Chemistry Letters, 1996, # 9, p. 747 - 748
[2] Patent: WO2013/160273, 2013, A1, . Location in patent: Page/Page column 108
  • 6
  • [ 292638-85-8 ]
  • [ 17012-21-4 ]
Reference: [1] Patent: US2015/45408, 2015, A1, . Location in patent: Paragraph 0498-0499
  • 7
  • [ 51535-00-3 ]
  • [ 17012-21-4 ]
YieldReaction ConditionsOperation in experiment
3% With hydrogenchloride; sodium hydroxide In tetrahydrofuran; dichloromethane EXAMPLE 218
1-[1-(Anthracene-9-carbonyl)-piperidin-4-yl]-pyrrolidine-3-carboxylic acid diethylamide
To a solution of 1-benzyl-5-oxo-pyrrolidine-3-carboxylic acid methyl ester (30 mmol, 7 g) in anhydrous tetrahydrofuran (40 ml) was added borane-tetrahydrofuran solution (1M, 50 mmol, 50 mL) at ambient temperature.
When gas evolution had subsided the solution was heated under reflux for 75 min then stirred for 16 hr at ambient temperature.
Hydrochloric acid (6M) was added dropwise (ca. 5 mL) and the mixture was stirred at ambient temperature for 1 hr before removing the solvent under vacuum.
The residue was dissolved in dichloromethane and the solution was washed with dilute sodium hydroxide solution.
The dichloromethane solution was then extracted with dilute hydrochloric acid (*3), the extracts combined, made basic by addition of sodium hydroxide and extracted with dichloromethane (*3).
The combined organic extract was dried over anhydrous sodium sulfate and the solvent was removed under vacuum.
The product was purified by chromatography on silica gel eluding with 5percent methanol-dichloromethane to give 1-benzyl-pyrrolidine-3-carboxylic acid methyl ester (200 mg, 3percent).
MS: 220.2 [M+H]+
Reference: [1] Patent: US2003/187254, 2003, A1,
  • 8
  • [ 53215-95-5 ]
  • [ 17012-21-4 ]
Reference: [1] Chemistry Letters, 1984, p. 1117 - 1120
[2] Chemical & Pharmaceutical Bulletin, 1985, vol. 33, # 7, p. 2762 - 2766
[3] Patent: US2015/45408, 2015, A1,
[4] Patent: CN104817549, 2017, B,
  • 9
  • [ 292638-85-8 ]
  • [ 17012-21-4 ]
Reference: [1] Patent: EP1221441, 2002, A2, . Location in patent: Page 199
  • 10
  • [ 617-52-7 ]
  • [ 17012-21-4 ]
Reference: [1] European Journal of Organic Chemistry, 2005, # 4, p. 673 - 682
[2] Chemistry - A European Journal, 2017, vol. 23, # 9, p. 2005 - 2009
  • 11
  • [ 100-46-9 ]
  • [ 17012-21-4 ]
Reference: [1] Chemistry - A European Journal, 2017, vol. 23, # 9, p. 2005 - 2009
[2] Patent: CN104817549, 2017, B,
  • 12
  • [ 50-00-0 ]
  • [ 141-32-2 ]
  • [ 17136-36-6 ]
  • [ 17012-21-4 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 1987, vol. 60, # 11, p. 4079 - 4090
  • 13
  • [ 17012-21-4 ]
  • [ 24424-99-5 ]
  • [ 122684-33-7 ]
Reference: [1] European Journal of Organic Chemistry, 2005, # 4, p. 673 - 682
[2] Organic Letters, 2005, vol. 7, # 15, p. 3287 - 3289
[3] Patent: WO2013/160273, 2013, A1, . Location in patent: Page/Page column 108; 109
[4] Patent: US2015/45408, 2015, A1, . Location in patent: Paragraph 0502-0503
  • 14
  • [ 17012-21-4 ]
  • [ 50893-53-3 ]
  • [ 24424-99-5 ]
  • [ 122684-33-7 ]
Reference: [1] Patent: US2003/229226, 2003, A1, . Location in patent: Page 16-17
  • 15
  • [ 17012-21-4 ]
  • [ 188527-21-1 ]
Reference: [1] Patent: CN104817549, 2017, B,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 17012-21-4 ]

Amino Acid Derivatives

Chemical Structure| 895243-39-7

[ 895243-39-7 ]

trans-1-Benzyl-4-(ethoxycarbonyl)pyrrolidine-3-carboxylic acid

Similarity: 0.96

Chemical Structure| 261896-27-9

[ 261896-27-9 ]

trans-Ethyl 1-benzyl-4-methylpyrrolidine-3-carboxylate

Similarity: 0.96

Chemical Structure| 1027-35-6

[ 1027-35-6 ]

Ethyl 1-benzyl-4-oxopyrrolidine-3-carboxylate

Similarity: 0.87

Chemical Structure| 17945-54-9

[ 17945-54-9 ]

Ethyl 3-(benzylamino)-3-methylbutanoate

Similarity: 0.78

Chemical Structure| 23583-21-3

[ 23583-21-3 ]

Ethyl 3-(benzylamino)propanoate

Similarity: 0.76